drugset / Trial / NCT01375933
A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the comparability of the phase 3 lot and a single commercial lot of NicVAX in healthy smokers.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NicVAX | Vaccine | — | — |
Indications
No indication recorded.